Literature DB >> 3008727

Selective antimitochondrial agents inhibit calmodulin.

W L Bodden, S T Palayoor, W N Hait.   

Abstract

Certain cationic-lipophilic compounds are known to selectively accumulate in tumor mitochondria and inhibit energy production. Since these substances bear a structural resemblance to known inhibitors of calmodulin, we studied whether rhodamine-123 or a bis-4-aminoquinaldinium could antagonize the action of calmodulin. Rhodamine-123 (IC50 = 58 microM) and dequalinium (IC50 = 1 microM) inhibited the activity of a calmodulin-stimulated cyclic nucleotide phosphodiesterase. Propylinium, a compound similar to dequalinium except for having a 3 rather than 10 carbon alkyl bridge connecting two non-substituted quinoline rings, had no inhibitory effect. Kinetic analysis showed that dequalinium competitively inhibited calmodulin's activation of phosphodiesterase. We also studied the antiproliferative effects of the compounds on the C6 astrocytoma cell line. Rhodamine-123 and dequalinium inhibited the proliferation of this cell line while propylinium had no effect. These studies demonstrate that rhodamine-123 and dequalinium are calmodulin-antagonists and inhibit cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008727     DOI: 10.1016/0006-291x(86)90032-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Disruption of mitochondrial function as the basis of the trypanocidal effect of trifluoperazine on Trypanosoma cruzi.

Authors:  J L Lacuara; S R de Barioglio; P P de Oliva; A S Bernacchi; A F de Culasso; J A Castro; B M Franke de Cazzulo; J J Cazzulo
Journal:  Experientia       Date:  1991-06-15

Review 2.  Small mitochondria-targeting molecules as anti-cancer agents.

Authors:  Feng Wang; Marcia A Ogasawara; Peng Huang
Journal:  Mol Aspects Med       Date:  2009-12-06

3.  DQAsomes: a novel potential drug and gene delivery system made from Dequalinium.

Authors:  V Weissig; J Lasch; G Erdos; H W Meyer; T C Rowe; J Hughes
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

4.  Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.

Authors:  M J Weiss; J R Wong; C S Ha; R Bleday; R R Salem; G D Steele; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 5.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Dequalinium-induced cell death of yeast expressing alpha-synuclein-GFP fusion protein.

Authors:  In-Hwan Lee; Hui-Young Kim; Myunghye Kim; Ji-Sook Hahn; Seung R Paik
Journal:  Neurochem Res       Date:  2008-03-07       Impact factor: 3.996

7.  Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.

Authors:  Kristen M Smith; Alessandro Datti; Mayumi Fujitani; Natalie Grinshtein; Libo Zhang; Olena Morozova; Kim M Blakely; Susan A Rotenberg; Loen M Hansford; Freda D Miller; Herman Yeger; Meredith S Irwin; Jason Moffat; Marco A Marra; Sylvain Baruchel; Jeffrey L Wrana; David R Kaplan
Journal:  EMBO Mol Med       Date:  2010-09       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.